Pharmacoepidemiology

Dr. Weiss has been an epidemiologist for 50 years. While much of his work has been directed towards cancer epidemiology and epidemiologic methods, he has had a consistent interest in clinical epidemiology, i.e. the study of the outcome of illness. In 1986, he published a book on this subject - Clinical Epidemiology: The Study of the Outcome of Illness (Monographs in Epidemiology and Biostatistics, 36) - which is now in its third edition.

Paul Dluzniewski is currently a Director in the Center for Observational Research at Amgen. As product area lead for the cardiovascular-metabolic group, his work is focused on therapies used to treat patients at elevated risk of cardiovascular disease. He leads evidence generation efforts by conducting epidemiologic research to inform the benefit-risk profile of Amgen’s therapies and highlight the clinical value of both marketed and pipeline products.

Dr. Annette Regan is an Adjunct Assistant Professor at the Department of Epidemiology, UCLA Fielding School of Public Health and an Assistant Professor at the Texas A&M University School of Public Health. Her research is dedicated to epidemiological investigations which aim to inform global policy for improving maternal and child health. She completed her epidemiology training at the Emory University Rollins School of Public Health (MPH, 2006) and infectious disease epidemiology training at the School of Pathology and Laboratory Medicine at University of Western Australia (PhD, 2016).

Marissa Seamans, PhD, MSPH, is an Assistant Professor in the Department of Epidemiology. Dr. Seamans’ research focuses on the intersection of social epidemiology and pharmacoepidemiology to address substance use and mental health. Her work explores the use of large healthcare databases to examine prescription drug use in families and the effectiveness of treatments for mental health and substance use disorders. Methodologically, Dr.

Dr. Greene developed a passion for Epidemiology while earning her Masters of Public Health at UCLA. After spending the first 20 years of professional life as a high-risk obstetrics and gynecology research sonographer, she found that the discipline of Epidemiology would allow her to begin answering some of the many challenging questions that had arisen in her chosen field of maternal and child health –a nd to finally have the analytic tools needed to search for the answers in valid and reproducible ways.

Biography: